{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:09:30Z","timestamp":1762506570786},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,4,30]],"date-time":"2015-04-30T00:00:00Z","timestamp":1430352000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.ijid.2015.04.019","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T03:17:54Z","timestamp":1435807074000},"page":"80-84","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"special_numbering":"C","title":["Treating Ebola patients: a \u2018bottom up\u2019 approach using generic statins and angiotensin receptor blockers"],"prefix":"10.1016","volume":"36","author":[{"given":"David S.","family":"Fedson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ole Martin","family":"Rordam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2015.04.019_bib0265","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1414992","article-title":"West African Ebola epidemic after one year\u2014slowing but not yet under control","volume":"372","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0270","unstructured":"Sissoko D, Anglaret X, Malvy D, Folkesson E, Abdoul M, Shepherd S, et al. Favipiravir in patients with Ebola virus disease: early results of the JIKI trial in Guinea. Abstract 103-ALB. Conference on Retroviruses and Opportunistic Infections, Seattle, WA, USA, February 23\u201326, 2015."},{"key":"10.1016\/j.ijid.2015.04.019_bib0275","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1056\/NEJMoa1411677","article-title":"A case of severe Ebola virus infection complicated by Gram-negative septicemia","volume":"371","author":"Kreuels","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0280","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1056\/NEJMoa1409838","article-title":"Clinical care of two patients with Ebola virus disease in the United States","volume":"371","author":"Lyon","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0285","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/S0140-6736(14)62384-9","article-title":"Severe Ebola virus disease with vascular leakage and multiorgan failure: treatment of a patient in intensive care","volume":"385","author":"Wolf","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.04.019_bib0290","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1253\/circj.CJ-10-0110","article-title":"Pleotropic effects of statins\u2014basic research and clinical perspectives","volume":"74","author":"Zhou","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.ijid.2015.04.019_bib0295","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.2174\/138161212802481282","article-title":"Effects of ACE inhibitors and angiotensin receptor blockers on inflammation","volume":"18","author":"Di Raimondo","year":"2012","journal-title":"Curr Pharmacol Des"},{"key":"10.1016\/j.ijid.2015.04.019_bib0300","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1089\/ars.2013.5430","article-title":"Statins as regulators of redox state in the vascular endothelium: beyond lipid lowering","volume":"20","author":"Margaritis","year":"2014","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/j.ijid.2015.04.019_bib0305","doi-asserted-by":"crossref","first-page":"L575","DOI":"10.1152\/ajplung.00428.2007","article-title":"Endothelial cell barrier protection by simvastatin: GTPase regulation and NADPH oxidase inhibition","volume":"295","author":"Chen","year":"2008","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"10.1016\/j.ijid.2015.04.019_bib0310","doi-asserted-by":"crossref","first-page":"e59233","DOI":"10.1371\/journal.pone.0059233","article-title":"Inhibition of Rho and Rac geranylgeranylation by atorvastatin is critical for preservation of endothelial junction integrity","volume":"8","author":"Xiao","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ijid.2015.04.019_bib0315","doi-asserted-by":"crossref","first-page":"C267","DOI":"10.1152\/ajpcell.00138.2011","article-title":"Angiotensin II increases the permeability and PV-1 expression of endothelial cells","volume":"302","author":"Bodor","year":"2012","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/j.ijid.2015.04.019_bib0320","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1086\/379727","article-title":"Ebola hemorrhagic fever and septic shock","volume":"188","author":"Bray","year":"2003","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2015.04.019_bib0325","doi-asserted-by":"crossref","first-page":"S810","DOI":"10.1093\/infdis\/jir299","article-title":"Basic clinical and laboratory features of filoviral hemorrhagic fever","volume":"204","author":"Kortepeter","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2015.04.019_bib0330","doi-asserted-by":"crossref","first-page":"507","DOI":"10.4161\/viru.24530","article-title":"Biomarkers of endothelial activation\/dysfunction in infectious diseases","volume":"4","author":"Page","year":"2013","journal-title":"Virulence"},{"key":"10.1016\/j.ijid.2015.04.019_bib0335","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/joim.12331","article-title":"Endothelial barrier dysfunction in septic shock","volume":"277","author":"Opal","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0340","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.antiviral.2011.10.019","article-title":"Do viral infections mimic bacterial sepsis? The role of microvascular permeability: a review of mechanisms and methods","volume":"93","author":"Steinberg","year":"2012","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2015.04.019_bib0345","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1126\/science.1259595","article-title":"Host generic diversity enables Ebola hemorrhagic fever pathogenesis and resistance","volume":"346","author":"Rasmussen","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ijid.2015.04.019_bib0350","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.jaci.2015.02.015","article-title":"Ebola: a holistic approach is required to achieve effective management and control","volume":"135","author":"Roca","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.ijid.2015.04.019_bib0355","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cis733","article-title":"Population-based study of statins, angiotensin II receptor blockers and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes","volume":"55","author":"Mortensen","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.04.019_bib0360","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/infdis\/jir695","article-title":"Association between use of statins and mortality among patients hospitalized with laboratory-confirmed influenza virus infections: a multistate study","volume":"205","author":"Vandermeer","year":"2012","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2015.04.019_bib0365","doi-asserted-by":"crossref","first-page":"R231","DOI":"10.1186\/cc11895","article-title":"Randomized double-blind placebo-controlled trial of 40mg\/day of atorvastatin in reducing the severity of sepsis in ward patients (ASEPSIS Trial)","volume":"16","author":"Patel","year":"2012","journal-title":"Crit Care"},{"key":"10.1016\/j.ijid.2015.04.019_bib0370","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/path.2666","article-title":"Selective blockade of endothelial NF-\u03baB pathway differentially affects systemic inflammation and multiple organ dysfunction and injury in septic mice","volume":"220","author":"Xu","year":"2010","journal-title":"J Pathol"},{"key":"10.1016\/j.ijid.2015.04.019_bib0375","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1161\/01.CIR.0000165070.46111.9F","article-title":"Effect of atorvastatin and irbesartan, alone and in combination, on postprandial endothelial dysfunction, oxidative stress and inflammation in type 2 diabetic patients","volume":"111","author":"Ceriello","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.ijid.2015.04.019_bib0380","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1253\/circj.CJ-13-1494","article-title":"Statins and renin\u2013angiotensin system inhibitor combination treatment to prevent cardiovascular disease","volume":"78","author":"Lee","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/j.ijid.2015.04.019_bib0385","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1093\/infdis\/jiu474","article-title":"A practical treatment for patients with Ebola virus disease","volume":"211","author":"Fedson","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2015.04.019_bib0390","first-page":"190ra79","article-title":"FDA-approved selective estrogen receptor modulators inhibit Ebola virus infection","volume":"5","author":"Johansen","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0395","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1128\/JVI.78.8.4330-4341.2004","article-title":"Rapid diagnosis of Ebola hemorrhagic fever by reverse transcription-PCR in an outbreak setting and assessment of patient viral load as a predictor of outcome","volume":"78","author":"Towner","year":"2004","journal-title":"J Virol"},{"key":"10.1016\/j.ijid.2015.04.019_bib0400","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1056\/NEJMp1413084","article-title":"Ebola virus disease in West Africa\u2014clinical manifestations and management","volume":"371","author":"Chertow","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0405","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1073\/pnas.1502619112","article-title":"Human Ebola virus infection results in substantial immune activation","volume":"112","author":"McElroy","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.ijid.2015.04.019_bib0410","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1126\/science.345.6198.718","article-title":"Debate erupts on \u2018repurposed\u2019 drugs for Ebola","volume":"345","author":"Enserink","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.ijid.2015.04.019_bib0415","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s12915-014-0080-6","article-title":"Ebolavirus in West Africa, and the use of experimental therapies or vaccines","volume":"12","author":"Hoenen","year":"2014","journal-title":"BMC Biol"},{"key":"10.1016\/j.ijid.2015.04.019_bib0420","unstructured":"World Health Organization. Meeting of the Scientific and Technical Advisory Committee on Ebola experimental interventions\u2014briefing note. WHO; November 13, 2014. Available at: http:\/\/apps.who.int\/medicines\/ebola-treatment\/scientific_tech_meeting\/en\/index.html (accessed 10.04.14)."},{"key":"10.1016\/j.ijid.2015.04.019_bib0425","doi-asserted-by":"crossref","first-page":"a007153","DOI":"10.1101\/cshperspect.a007153","article-title":"Nonpathogenic simian immunodeficiency virus infections","volume":"2","author":"Klatt","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2015.04.019_bib0430","doi-asserted-by":"crossref","first-page":"S1000","DOI":"10.1093\/infdis\/jir337","article-title":"Real-time monitoring of cardiovascular function in rhesus macaques infected with Zaire ebolavirus","volume":"204","author":"Kortepeter","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/j.ijid.2015.04.019_bib0435","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1473-3099(14)70956-9","article-title":"Ebola in West Africa: from disease outbreak to humanitarian crisis","volume":"14","author":"Piot","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.ijid.2015.04.019_bib0440","unstructured":"M\u00e9decins sans Fronti\u00e8res. Pushed to the limit and beyond: a year into the largest ever Ebola outbreak. MSF; 2015. Available at: http:\/\/www.msf.org.uk\/sites\/uk\/files\/ebola_-_pushed_to_the_limit_and_beyond.pdf (accessed 10.04.14)."},{"key":"10.1016\/j.ijid.2015.04.019_bib0445","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.ijid.2014.12.002","article-title":"Guidelines for treatment of patients with Ebola virus disease are urgently needed","volume":"30","author":"Petersen","year":"2015","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ijid.2015.04.019_bib0450","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1411249","article-title":"Clinical presentation of patients with Ebola virus disease in Conakry, Guinea","volume":"372","author":"Bah","year":"2015","journal-title":". N Engl J Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0455","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1164\/rccm.201408-1514CP","article-title":"Caring for critically ill patients with Ebola virus disease. Perspectives from West Africa","volume":"190","author":"Fowler","year":"2014","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0460","doi-asserted-by":"crossref","first-page":"2001","DOI":"10.1016\/S0140-6736(14)62316-3","article-title":"Ebola virus disease: clinical care and patient-centred research","volume":"384","author":"Roberts","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.04.019_bib0465","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/S0140-6736(14)62353-9","article-title":"Ebola: the battle plan must include specific treatments","volume":"385","author":"Dunning","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.04.019_bib0470","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(14)62250-9","article-title":"Provision of care for Ebola","volume":"384","author":"Jacobs","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.04.019_bib0475","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0140-6736(15)60711-5","article-title":"Ebola and provision of critical care","volume":"385","author":"Brown","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.04.019_bib0480","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1016\/S0140-6736(15)60712-7","article-title":"Ebola and provision of critical care","volume":"385","author":"Murthy","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2015.04.019_bib0485","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1057\/palgrave.jphp.3200147","article-title":"From scarcity to abundance: pandemic vaccines and other agents for \u201chave not\u201d countries","volume":"28","author":"Fedson","year":"2007","journal-title":"J Public Health Policy"},{"key":"10.1016\/j.ijid.2015.04.019_bib0490","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.tim.2014.04.002","article-title":"Post-exposure therapy of filovirus infections","volume":"22","author":"Wong","year":"2014","journal-title":"Trends Microbiol"},{"key":"10.1016\/j.ijid.2015.04.019_bib0495","doi-asserted-by":"crossref","first-page":"253ps10","DOI":"10.1126\/scitranslmed.3009872","article-title":"Emerging viral diseases: confronting threats with new technologies","volume":"6","author":"Marston","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ijid.2015.04.019_bib0500","doi-asserted-by":"crossref","first-page":"e1003467","DOI":"10.1371\/journal.ppat.1003467","article-title":"Emerging infectious diseases: threats to human health and global stability","volume":"9","author":"Morens","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/j.ijid.2015.04.019_bib0505","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.antiviral.2013.06.018","article-title":"Treating influenza with statins and other immunomodulatory agents","volume":"99","author":"Fedson","year":"2013","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ijid.2015.04.019_bib0510","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1093\/cid\/cit695","article-title":"How will physicians respond to the next influenza pandemic?","volume":"58","author":"Fedson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2015.04.019_bib0515","unstructured":"Multiple treatments for Ebola virus disease (EVD). NCT02380625. ClinicalTrials.gov, NIH, USA; 2015. Available at: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02380625 (accessed 10.04.14)."},{"key":"10.1016\/j.ijid.2015.04.019_bib0520","first-page":"40","article-title":"As Ebola wanes, trials jockey for patients","volume":"348","author":"Kupperschmidt","year":"2015","journal-title":"Science"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121500106X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121500106X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,4]],"date-time":"2020-09-04T08:17:03Z","timestamp":1599207423000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197121500106X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":52,"alternative-id":["S120197121500106X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2015.04.019","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating Ebola patients: a \u2018bottom up\u2019 approach using generic statins and angiotensin receptor blockers","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2015.04.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}